At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,895 enrolled
Drug / intervention
SMILE Computerized Decision-Aidother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Implementing the Decision-Aid for Lupus (IDEAL Strategy)
In Brief
An observational study evaluating SMILE Computerized Decision-Aid for Systemic Lupus Erythematosus. Completed, enrolled 1,895 participants across 1 site.
Detailed Summary
The study will attempt to put into practice a shared decision making (SDM) strategy, using an individualized, computerized decision- aid (DA) for Systemic lupus erythematosus (SLE).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Lupus Erythematosus
CountriesUnited States
CollaboratorsPatient-Centered Outcomes Research Institute
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 2018
Enrollment StartDec 2018
Primary CompletionNov 2024
Study CompletionJun 2025
TodayJul 2026
First PostedNov 8, 2018
Enrollment StartDec 15, 2018
Primary CompletionNov 15, 2024
Study CompletionJun 10, 2025
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 7.6 years ago
Interventions
SMILE Computerized Decision-Aidother
SMILE is a computerized decision-aid designed to give lupus patients information about lupus, treatments for lupus available to them, as well as side effects. This will be administered at every lupus clinic session. Every patient will see the SMILE Computerized Decision-Aid at their index baseline clinic visit.